Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1,863 | 3 | 45.4% |
| Food and Beverage | $1,144 | 44 | 27.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,100 | 3 | 26.8% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $1,863 | 3 | $0 (2017) |
| Tandem Diabetes Care, Inc. | $1,100 | 3 | $0 (2020) |
| Amgen Inc. | $516.85 | 20 | $0 (2024) |
| Novo Nordisk Inc | $180.05 | 5 | $0 (2024) |
| Medtronic, Inc. | $105.60 | 1 | $0 (2024) |
| Medtronic MiniMed, Inc. | $89.33 | 5 | $0 (2020) |
| Astellas Pharma US Inc | $38.14 | 2 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $33.07 | 2 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $32.33 | 1 | $0 (2024) |
| Echosens North America, Inc. | $29.03 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $417.66 | 16 | Amgen Inc. ($175.71) |
| 2023 | $199.71 | 6 | Amgen Inc. ($178.07) |
| 2022 | $70.37 | 3 | Echosens North America, Inc. ($29.03) |
| 2021 | $28.32 | 1 | Amgen Inc. ($28.32) |
| 2020 | $849.63 | 10 | Tandem Diabetes Care, Inc. ($700.00) |
| 2019 | $167.99 | 4 | Novo Nordisk Inc ($99.13) |
| 2018 | $510.66 | 7 | Tandem Diabetes Care, Inc. ($400.00) |
| 2017 | $1,863 | 3 | NOVARTIS PHARMACEUTICALS CORPORATION ($1,863) |
All Payment Transactions
50 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: Oncology | ||||||
| 12/11/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Neuroscience | ||||||
| 12/04/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $29.79 | General |
| Category: Bone Health | ||||||
| 11/21/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $105.60 | General |
| Category: Durable Pump | ||||||
| 10/24/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: RESPIRATORY | ||||||
| 10/09/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $30.51 | General |
| Category: Bone Health | ||||||
| 10/01/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: Diabetes | ||||||
| 07/31/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $24.62 | General |
| Category: Bone Health | ||||||
| 06/19/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: Bone Health | ||||||
| 06/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: Inflammation | ||||||
| 04/22/2024 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: Bone Health | ||||||
| 03/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $32.33 | General |
| Category: DIABETES | ||||||
| 03/13/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Biological | ||||||
| 03/04/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $22.47 | General |
| Category: Inflammation | ||||||
| 02/21/2024 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $9.75 | General |
| Category: Bone Health | ||||||
| 01/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: Diabetes | ||||||
| 09/05/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: Biological | ||||||
| 07/31/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: Bone Health | ||||||
| 06/29/2023 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Bone Health | ||||||
| 06/07/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $7.32 | General |
| Category: Bone Health | ||||||
| 04/26/2023 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: Bone Health | ||||||
| 03/01/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $8.89 | General |
| Category: Bone Health | ||||||
| 11/29/2022 | Echosens North America, Inc. | FibroScan (Device) | Food and Beverage | Cash or cash equivalent | $29.03 | General |
| Category: Elastography | ||||||
| 10/10/2022 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: Bone Health | ||||||
| 05/17/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $20.11 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| RESEARCH RELATED PUBLICATION SUPPORT | NOVARTIS PHARMACEUTICALS CORPORATION | $1,863 | 3 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 218 | 368 | $110,658 | $26,618 |
| 2022 | 6 | 144 | 204 | $66,934 | $18,598 |
| 2021 | 8 | 196 | 352 | $61,399 | $21,000 |
| 2020 | 15 | 401 | 642 | $80,014 | $21,267 |
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 95 | 177 | $59,210 | $13,510 | 22.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 42 | 64 | $29,896 | $7,702 | 25.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 19 | 19 | $10,839 | $2,742 | 25.3% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 23 | 55 | $5,035 | $1,298 | 25.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $4,752 | $966.27 | 20.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 28 | 42 | $926.10 | $399.84 | 43.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 44 | 68 | $22,747 | $6,455 | 28.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 33 | 46 | $21,488 | $5,857 | 27.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 25 | 25 | $14,262 | $3,828 | 26.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $5,184 | $1,423 | 27.5% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 12 | 30 | $2,746 | $814.91 | 29.7% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 18 | 23 | $507.15 | $219.87 | 43.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 57 | 115 | $30,736 | $10,293 | 33.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 13 | 28 | $9,576 | $3,934 | 41.1% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 18 | 18 | $8,586 | $2,507 | 29.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 20 | 38 | $3,914 | $2,398 | 61.3% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2021 | 15 | 38 | $4,028 | $1,047 | 26.0% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 29 | 45 | $2,925 | $436.95 | 14.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 12 | 12 | $648.00 | $196.32 | 30.3% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2021 | 32 | 58 | $986.00 | $187.34 | 19.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 70 | 135 | $34,560 | $9,266 | 26.8% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 13 | 31 | $10,602 | $3,321 | 31.3% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 20 | 20 | $9,540 | $2,936 | 30.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 16 | 18 | $1,854 | $1,022 | 55.1% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2020 | 16 | 37 | $3,922 | $999.10 | 25.5% |
About Ekaterina Manuylova
Ekaterina Manuylova is a Endocrinology, Diabetes & Metabolism healthcare provider based in Salem, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/23/2012. The National Provider Identifier (NPI) number assigned to this provider is 1831459817.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ekaterina Manuylova has received a total of $4,107 in payments from pharmaceutical and medical device companies, with $417.66 received in 2024. These payments were reported across 50 transactions from 16 companies. The most common payment nature is "" ($1,863).
As a Medicare-enrolled provider, Manuylova has provided services to 959 Medicare beneficiaries, totaling 1,566 services with total Medicare billing of $87,484. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism|Endocrinology, Diabetes & Metabolism
- Location Salem, OR
- Active Since 05/23/2012
- Last Updated 12/30/2022
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1831459817
Products in Payments
- SIGNIFOR (Drug) $1,863
- t:slim X2 insulin pump (Device) $700.00
- t-slim insulin pump (Device) $400.00
- EVENITY (Biological) $393.46
- Ozempic (Drug) $140.18
- MINIMED 780G (Device) $105.60
- Prolia (Biological) $69.59
- Minimed 670G System (Device) $52.75
- Otezla (Drug) $38.80
- Veozah (Drug) $38.14
- JARDIANCE (Drug) $32.33
- FibroScan (Device) $29.03
- DEXCOM G6 CGM SYSTEM (Device) $27.79
- Minimed 770G System (Device) $19.03
- AFREZZA (Drug) $18.31
- XYOSTED (Drug) $18.17
- INVOKANA (Drug) $17.85
- Cologuard Collection Kit (Device) $17.72
- Guardian Connect (Device) $17.55
- SPRAVATO (Drug) $15.22
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Salem
Mahdere Asfaw, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $3,166
Kamran Rasul, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $2,951
Ali Iranmanesh
Endocrinology, Diabetes & Metabolism — Payments: $1,801
Kathleen Glymph, D.o, D.O
Endocrinology, Diabetes & Metabolism — Payments: $792.68
Mr. Thomas Chamberlin, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $461.58
Mr. Christian Duren, Pa, PA
Endocrinology, Diabetes & Metabolism — Payments: $20.06